Daniel Catenacci (@doccatenacci) 's Twitter Profile
Daniel Catenacci

@doccatenacci

Medical Oncologist. "Targeted therapies for targeted populations”

ID: 2561811649

linkhttps://www.linkedin.com/in/daniel-catenacci-58779940/ calendar_today11-06-2014 17:51:29

1,1K Tweet

2,2K Takipçi

376 Takip Edilen

Daniel Catenacci (@doccatenacci) 's Twitter Profile Photo

ILSON David Santhosh Ambika Do you call the benefit of CROSS over surgery alone ‘modest’ with a HR of 0.75? FLOT had HR of 0.76 over ECF which previously had a HR of 0.74 over surgery alone. There is nothing more to say. Ultimately you either see it and it is obvious or you dont. But you eventually will.